Arrowhead Sees Partnership for Calando Subsidiary by Year End

The company also released its fiscal third-quarter financial results, posting a drop in losses amid decreased expenses.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.